Abstract
QSAR study on a data set of 5-lipoxygenase inhibitors (1-phenyl [2H]-tetrahydro-triazine-3-one analogues) was carried out by using Support Vector Regression (SVR) and physicochemical parameters. Wrapper methods were used to select descriptors, while Leave-One-Out Cross Validation (LOOCV) method and independent set test were used to judge the predictive power of different models. We found out that the generalization ability of SVR model outperformed multiple linear regression (MLR) and Partial Least Squares (PLS) models in this work. An online web server for activity prediction is available at http://chemdata.shu.edu.cn/qsar5lip.
Keywords: Support vector regressions, 1-phenyl [2H]-tetrahydro-triazine-3-one analogues, Leave-one-out cross-validation, Feature selection, Wrapper, Multiple linear regression (MLR), Partial least squares (PLS) analysis
Medicinal Chemistry
Title:QSAR Study On 5-Lipoxygenase Inhibitors Based on Support Vector Machine
Volume: 8 Issue: 6
Author(s): Bing Niu, Qiang Su, Xiaochen Yuan, Wencong Lu and Juan Ding
Affiliation:
Keywords: Support vector regressions, 1-phenyl [2H]-tetrahydro-triazine-3-one analogues, Leave-one-out cross-validation, Feature selection, Wrapper, Multiple linear regression (MLR), Partial least squares (PLS) analysis
Abstract: QSAR study on a data set of 5-lipoxygenase inhibitors (1-phenyl [2H]-tetrahydro-triazine-3-one analogues) was carried out by using Support Vector Regression (SVR) and physicochemical parameters. Wrapper methods were used to select descriptors, while Leave-One-Out Cross Validation (LOOCV) method and independent set test were used to judge the predictive power of different models. We found out that the generalization ability of SVR model outperformed multiple linear regression (MLR) and Partial Least Squares (PLS) models in this work. An online web server for activity prediction is available at http://chemdata.shu.edu.cn/qsar5lip.
Export Options
About this article
Cite this article as:
Niu Bing, Su Qiang, Yuan Xiaochen, Lu Wencong and Ding Juan, QSAR Study On 5-Lipoxygenase Inhibitors Based on Support Vector Machine, Medicinal Chemistry 2012; 8 (6) . https://dx.doi.org/10.2174/1573406411208061108
DOI https://dx.doi.org/10.2174/1573406411208061108 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multifaceted Synthesis, Properties and Applications of Polyurethanes and its Composites
Current Organic Chemistry Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications
Current Drug Targets Gastrin-Releasing Peptide as a Molecular Target for Inflammatory Diseases: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Alkynes as Privileged Synthons in Selected Organic Name Reactions
Current Organic Synthesis Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma
Mini-Reviews in Medicinal Chemistry Doxycycline in Mitochondrial Mediated Pathway of Apoptosis: A Systematic Review
Anti-Cancer Agents in Medicinal Chemistry Relevant Physicochemical Descriptors of “Soft Nanomedicines” to Bypass Biological Barriers
Current Pharmaceutical Design Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Anticancer Antifolates: Current Status and Future Directions
Current Pharmaceutical Design Biopolymer-based Scaffolds for Tissue Engineering Applications
Current Drug Targets uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets New Technologies for Drug Delivery Across the Blood Brain Barrier
Current Pharmaceutical Design A Better Platinum-Based Anticancer Drug Yet to Come?
Anti-Cancer Agents in Medicinal Chemistry The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Novel Insights into Targeting ATP-Binding Cassette Transporters for Antitumor Therapy
Current Medicinal Chemistry Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Current Medicinal Chemistry Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Notch Signalling Pathways and Their Importance in the Treatment of Cancers
Current Drug Targets Catalytic Activity of Certain Antibodies as a Potential Tool for Drug Synthesis and for Directed Prodrug Therapies
Current Medicinal Chemistry Kinase Inhibitor Conjugates
Current Pharmaceutical Design